The USPTO is conducting a roundtable to gather further information and public input in preparing a final report to Congress as required by Section 27 of the AIA (Pub. L. No. 112-29), which directs the USPTO to study effective ways to provide independent, confirming genetic diagnostic test activity where gene patents and exclusive licensing for primary genetic diagnostic tests exist.
The roundtable will be held on Thursday, January 10, 2013, from 1:00pm to 4:00pm at the USPTO's Madison Auditorium North, 600 Dulany Street, Alexandria, Virginia 22314. The roundtable is also accessible via live webcast as follows.
Event number: 993 566 914
Event password: 123456
FOR FURTHER INFORMATION CONTACT:
Saurabh Vishnubhakat, Expert Advisor,
Office of Chief Economist, by telephone
at 571-272-9300, or by email at